- eukaryotic protein kinase enzymes (with function in the cell)
	- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698043/

Akt/PKB	
- Glucose storage regulation in the form of glycogen by phosphorylation of GSK3.
- Regulation of cell survival via phosphorylation of ASK1.
- Regulation of many processes, including metabolism, proliferation, cell survival, growth, and angiogenesis.

AMPK	
- Control of food intake.
- Key role in carbohydrate and lipid metabolism in skeletal muscle.
- Promotion of catabolic pathways to generate ATP production and inhibition of anabolic pathways.
- Negative regulation of mTOR signaling.

ASK1	
- Positive regulation of vascular smooth muscle proliferation.
- Crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation required for sustained activations of JNK/p38 MAP kinases and apoptosis.

CDKs	
- Regulation of cell cycle and cell division.
- Modulation of transcription in response to several extra- and intracellular cues.

CK2, CK2α	
- Positive regulation of cell growth and proliferation.
- Stimulation of Wnt signaling pathway.
- Regulation of signal transduction by p53 mediator.
- Repression of cysteine-type endopeptidases involved in apoptosis.
- Negative regulation of ubiquitin-dependent protein degradation.

EGFR	
- Regulation of angiogenesis, cell motility, differentiation, proliferation, and survival.
- Inhibition of apoptosis.
- Positive regulation of NFκB signaling.
- Activation of major downstream signaling cascades, including the RAS-RAF-MEK-ERK, PI3K-Akt, PLCγ-PKC, and STATs modules.

ERK1/2	
- Positive regulation of gene expression and translation.
- Regulation of proliferation, differentiation, and survival.
- Regulation of apoptosis and stress response.

FAK1	
- Positive regulation of PI3K and Akt/PKB signaling.
- Positive regulation of cell population proliferation and cell migration.
- Regulation of cell adhesion mediated by integrin.

FGFR	
- Cell proliferation, differentiation, maturation, and migration.
- Selective apoptosis during embriogenesis.
- Stimulation of MAPK, PI3K, and Akt/PKB signaling pathways.

GSK3β	
- A negative regulator in the hormonal control of glucose homeostasis, Wnt signaling, and the regulation of transcription factors and microtubules by inactivation of glycogen synthase, eIF2B, β-catenin, APC, JUN, and others.
- Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors.

IGF1-R	
- Regulation of cell growth and survival, suppression of apoptosis.
- Inactivation of MAPKK activity.
- Stimulation of MAPK, PI3K, and Akt/PKB signaling pathways.
- Positive regulation of cell population and migration.
- Regulation of JNK cascade.

IKKα	
- Essential for activation of members of the NF-κB family of transcription factors, which play a fundamental role in lymphocyte immunoregulation.
- Positive regulation of transcription by RNA pol II.

JAK1-3	
- Regulation of receptor signaling pathway via JAK-Stat.
- Mediates interleukin-7-induced activation of PI3K.

JNK	
- JNK phosphorylates heats shock transcription factor-1 (HSF-1) and suppresses its transcriptional activity.
- Stimulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway.

Lck	
- Activation of cysteine-type endopeptidase activity involved in apoptosis.
- Stimulation of Akt/PKB signaling.
- Lymphocyte activation and stimulation of leukocyte cell adhesion.
- Regulation of cell proliferation.

mTOR	
- mTORC1 complex functions as a nutrient/energy/redox sensor and controls protein synthesis.
- mTORC2 complex regulates actin cytoskeleton and Akt/PKB activity, thus affecting metabolism and survival.
- Promotion of activation of IGF-IR and InsR.

PDK1	
- Phosphorylation of activation loops and activation of protein kinases: Akt/PKB, RSKs (p70 and p90S6K), SGK, PKC, p21-activated kinase (PAK), and polo-like kinase 1.

- Regulation of PI3k/Akt/mTOR, Ras/MAPK, and c-Myc signaling pathways.
PKA	
- Regulation of metabolic pathways, cell cycle, proliferation, and differentiation.
- Regulation of translation on the elongation step.

PKC	
- Signal transduction in mediating the effects of many extracellular stimuli, including growth factors, hormones, and drugs.

PKG	
- Regulation of apoptosis and survival in neural cells.
- Regulation of platelet activation and adhesion, smooth muscle contraction, blood pressure, cardiac function, gene expression, feedback of the NO-signaling pathway, and hippocampal and cerebellar learning.

Src	
- Control of many functions, including cell adhesion, growth, movement, and differentiation.
- Regulation of embryonic development and cell growth.
- Suppression of cysteine-type endopeptidase activity involved in the apoptotic process.
- Activation of Akt/PKB activity.

VEGFR1/3	
- Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis.
- Promotes proliferation, survival, migration, and differentiation of endothelial cells.
- Promotes reorganization of the actin cytoskeleton.





Examples of natural products affecting protein kinase activity.


Compound		Target					Biological Effect


Tyr Protein Kinases

Alpinetin		Stat3					Altered protein expression levels of cyclin-D1, c-Myc, survivin, Bcl-2, Bax, TIMP-1, TIMP-2, MMP-2, MMP-9, as well as cleaved caspase-3 and PARP in SKOV3 cells.	
Auriculasin		VEGFR2					Inhibition of angiogenesis by modulating VEGFR2-related signaling pathways. 
										Inhibition of VEGFR2 activation, as well as phosphorylation of intracellular downstream protein kinases AKT, mTOR, PI3K, p38, ERK, and Src.
Cantharidin		JAK1/Stat3				Suppression of VEGF-induced activation of Stat3 and inhibition of JAK1 and ERK phosphorylation.	
Curcumin		IGF-1R					Inhibition of phosphorylation: IGF1R, IRS1, AKT, S6K, and 4EBP1 in the mouse keratinocyte cell line.	
				Src, PTK2				Inhibition activity of v-Src led to a reduction of Src-Tyr phosphorylation, decreased Src-mediated Shc phosphorylation, ERK activation, and cell proliferation in v-Src transformed cells.	
Emodin			JAK2					Inhibition of IL-6-induced JAK2/Stat3 pathway induced apoptosis.	
Her2/neu								Suppression of Her2/neu PTK activity and proliferation; repression of transformation and metastasis.	
Honokiol		EGFR					Inhibition of U251 and U-87 MG human glioma/glioblastoma cell viability, colony formation, and promoted apoptosis. Inhibition of cell migration/proliferation and invasion. 
										Induction of apoptosis and reduction of Bcl-2 expression, accompanied by an increase in Bax expression. Reduced expression of EGFR, CD133, and nestin. Suppression of AKT and ERK signaling pathway activation.	
Luteolin		VEGF/VEGFR2				Decreased VEGF, cell migration, and viability of triple-negative breast cancer cell lines MDA-MB-435.	
				EGFR					Inhibition of EGF-induced activities of EGFR signaling pathway in human breast cancer cell lines and PI3K/AKT, MAPK/ERK1/2, Stat3 signal pathways.	
Lymphostin		Lck						Inhibition of Src family kinase Lck activity in Jurkat T cells.	
Quercetin		JAK2/Stat3				Inhibition of hepatocellular carcinoma progression by modulating cell apoptosis, migration, invasion, and autophagy. Effects partly related to the JAK2/Stat3 signaling pathway.	
Tannic acid		EGFR, Stat1/3			Tannic acid binding to EGFR inhibited the tyrosine kinase activity, modulated the EGFR/JAK2/Stat1/3 and p38/ Stat1/ p21WAF1/CIP1 pathways, and induced G1-arrest and intrinsic apoptosis in breast carcinomas


Ser/Thr Protein Kinases

β-elemene		Cdc2					Cell cycle G2/M phase was arrested in A2780 and A2780/CP human ovarian carcinoma cells in vitro, 
										mediated by alterations in cyclin and CDK expression, the down-regulation of Cdc2, cyclin A, and cyclin B1, and the upregulation of p21WAF1/CIP1 and p53 proteins.	
Acacetin 
Genkwanin 
Isorhamnetin	Akt/PKB					Cell cycle arrested at G2/M as a result of PI3Kγ inhibition and inactivation of PI3K, AKT, mTOR, p70RSK, and ULK, resulting in apoptosis in human breast cancer cells.	
Alpinetin		ERK						Phosphorylation of IκBα protein, p65, p38, and ERK inhibited in LPS stimulated RAW 264.7 cells.	
Apigenin		CK2α					Inactivation of CK2α resulted in inhibition of the sphere-forming cell capacity of HeLa.	
				IKKα					Direct binding with IKKα attenuated kinase activity and suppressed NF-ĸB/p65 activation in human prostate cancer PC-3 and 22Rv1 cells.	
Artemisinin		IKKα					Exhibited anti-inflammatory activities in TPA-induced skin inflammation in mice; inhibited the expression of TRAF2 and RIP1; 
										inhibited TNFα induced NF-κB reporter gene expression, phosphorylation, and degradation of IκBα, and p65 nuclear translocation.	
Baicalin		PKC, MAPK				ROS production reduced, suppressed Casp3 cleavage for inducing apoptosis. 
										Inhibited activation of PKC/MAPK signaling pathway for down regulating JNK, p38, ERK, PKCα, and PKCδ in piglet monocytes stimulated by Haemophilus parasuis.	
Berberine		AMPK↑, mTOR				AMPK activated, as a major regulator of metabolic pathways, mTOR inhibited. mTOR targets: 4EBP1 and p70RSK down-regulated.	
				MLCK					Reduced amplitude of contraction in isolated duodenum and gastric strips in rats by inhibition of MLCK and down-regulation of MLC20 and Mg2+-ATPase activity.	
EGCG			RAF, MEK1/2, ERK1/2		Reduced protein levels of pEGFR, H-RAS, p-RAF, p-MEK1/2, and pERK1/2 in human thyroid carcinoma cells. Inhibition of the growth by induced apoptosis and down-regulated angiogenesis.	
Emodin			CK2						CK2 inhibition cancer cells to Fas and TRAIL ligand-induced apoptosis. CK2 inhibition enhanced the cytotoxicity of natural killer cells HepG2 and Hep3B in vivo.	
Genistein		PLK1					In human neuroblastoma SK-N-MC cells, the protein level of MDC1, p53, p21WAF/CIP1, and Bax increased in a dose-dependent manner. Phosphorylation of Chk2 and Cdc25C increased. 
										In addition, consistent with PLK1 down-regulation, Cdc25C phosphorylation inhibited at Ser-198. Down-regulation of proteins Chk2, Cdc25C, Cyclin B1, and Cdc2 as well as Bcl-2 resulted in neuronal apoptosis and G2/M cell cycle arrest.	
Hibiscone C		PI3K					Hibiscone C competitively inhibited PI3K activity in intact cells, slowed proliferation, and induced cell death.	
Luteolin		p90RSK, JNK1,			Luteolin exhibited anti-photoaging effects in vitro and in vivo by suppression of JNK1 and p90RSK activity and may have potential as a treatment for the prevention of skin aging.	
Quercetagetin	PIM1					PIM1 activity in intact RWPE2 prostate cancer cells inhibited in a dose-dependent manner. RWPE2 cells showed pronounced growth inhibition at inhibitor concentrations that blocked PIM1 kinase activity. 										 The ability of quercetagetin to inhibit the growth of other prostate epithelial cell lines varied in proportion to their levels of PIM1 protein.	
Quercetin		Akt/PKB, ERK			Akt/PKB and ERK inhibited, resulting in reduced phosphorylation of BAD and a strong activation of caspase-3.	
				CK2, Akt/PKB			CK2 and PI3K/Akt pathways inhibited in chronic lymphocytic leukaemia HG3 cells.	
Resveratrol		PKC, MAPK, IKKβ			TPA-induced expression of PKC inhibited in human mammary and oral epithelial cells PKCδ in human cervical cancer and affected PKC activity, inducing apoptosis in human colon carcinoma cells. 
										Activity of kinases: PKC, MAPK, IKKβ, and transcription factors: Stat3, HIFα, NF-κB, AP-1, were repressed, resulting in various responses to oncogenic stimuli
Scutellarein	PKC						Platelet adhesion and aggregation induced by multiple G protein coupled receptor agonists, such as thrombin, was inhibited in a concentration-dependent manner. 
										Scutellarein had a mild effect on intracellular Ca2+ mobilization and cAMP levels. The role of scutellarein as PKC inhibitor was confirmed by PKC activity analysis and molecular docking with PKCα and β
				PKC βI, PKC βII, PKCδ	PKC activity in the membrane fraction of thoracic aorta smooth muscle cells of diabetic rats inhibited. 
										The translocation inhibition of PKC in vivo and in vitro in diabetic rats may have value as a drug in the treatment of diabetic complications via its inhibition of PKC βI, βII, and δ.	
Songorine		GSK3β					Cell growth and metastasis in epithelial ovarian cancer suppressed via the GSK3β/β-catenin and Bcl2/Bax signaling pathways.	
